Table 5 DAVID Functional annotation resultsa
Term | Source | No. of genes | P-Value | Q-Value |
|---|---|---|---|---|
Serpin domain | INTERPRO | 7 | 4.30E-10 | 4.90E-08 |
Serpin family | INTERPRO | 7 | 4.30E-10 | 4.90E-08 |
SERPIN | SMART | 7 | 9.00E-10 | 3.30E-08 |
Serine protease inhibitor | UP_KEYWORDS | 7 | 4.20E-08 | 5.50E-06 |
Serine-type endopeptidase inhibitor activity | GOTERM_MF_DIRECT | 7 | 1.80E-07 | 1.80E-05 |
Protease inhibitor | UP_KEYWORDS | 7 | 3.70E-07 | 2.50E-05 |
Negative regulation of endopeptidase activity | GOTERM_BP_DIRECT | 6 | 1.20E-05 | 4.80E-03 |
Extracellular matrix structural constituent | GOTERM_MF_DIRECT | 5 | 2.70E-05 | 1.40E-03 |
Protease inhibitor I4, serpin, conserved site | INTERPRO | 4 | 7.40E-05 | 4.20E-03 |
Extracellular space | GOTERM_CC_DIRECT | 13 | 9.30E-05 | 1.00E-02 |
Extracellular matrix | GOTERM_CC_DIRECT | 7 | 9.50E-05 | 5.20E-03 |
Extracellular matrix organization | GOTERM_BP_DIRECT | 6 | 1.20E-04 | 2.40E-02 |
Propeptide: C-terminal propeptide | UP_SEQ_FEATURE | 3 | 1.40E-04 | 3.80E-02 |
Domain: Fibrillar collagen NC1 | UP_SEQ_FEATURE | 3 | 2.80E-04 | 3.70E-02 |
Extracellular matrix | UP_KEYWORDS | 6 | 3.00E-04 | 1.30E-02 |
Fibrillar collagen, C-terminal | INTERPRO | 3 | 3.30E-04 | 1.20E-02 |
Secreted | UP_KEYWORDS | 14 | 3.30E-04 | 1.10E-02 |
Skeletal system development | GOTERM_BP_DIRECT | 5 | 3.70E-04 | 4.70E-02 |
Ehlers-Danlos syndrome | UP_KEYWORDS | 3 | 4.60E-04 | 1.20E-02 |
COLFI | SMART | 3 | 4.70E-04 | 8.60E-03 |